Abstract
Objectives. Green fluorescent protein (GFP) and luciferase bioluminescence have been described for imaging ovarian cancer (OC) xenografts in mice. While tumor location can be assessed with these tools, extent of tumor burden is often difficult to assess due to the margins of light emission. Non-invasive imaging modalities to accurately follow tumor response and recurrence over time in vivo are needed for therapeutic studies in xenograft models. In this study, we sought to explore the utility of magnetic resonance imaging (MRI) in a murine model of ovarian cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
